Alcohol and substance abuse

Medical Clinics of North America

Volumn 85, Issue 3, 2001, Pages 779-801

  McRae, Aimee L ^b   Brady, Kathleen T ^b   Sonne, Susan C ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALCOHOL; AMANTADINE; AMFEBUTAMONE; AMLODIPINE; ANTICONVULSIVE AGENT; BENZODIAZEPINE; BROMOCRIPTINE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CHLORDIAZEPOXIDE; COCAINE; DESIPRAMINE; DIAMORPHINE; DIAZEPAM; DISULFIRAM; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUNITRAZEPAM; FLUOXETINE; FOLIC ACID; LORAZEPAM; MAGNESIUM; METHADONE; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NALTREXONE; NARCOTIC AGENT; NEUROLEPTIC AGENT; OXAZEPAM; PERGOLIDE; PLACEBO; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THIAMINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ALCOHOL ABUSE; ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; CLINICAL FEATURE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; NEUROBIOLOGY; PASSIVE IMMUNIZATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SIDE EFFECT; SUBSTANCE ABUSE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0035037188     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70340-0     Document Type: Article

References (122)

1. Age, alcohol and violent death: A postmortem study
2. Prevalence of prescription drug abuse: Data from the National Institute on Drug Abuse
3. Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline
4. Factors affecting outpatient treatment compliance of older male problem drinkers
5. Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria
6. Fluoxetine for cocaine dependence in methadone maintenance: Quantitative plasma and urine cocaine/benzoylecgonine concentrations
7. A controlled trial of fluoxetine in crack cocaine dependence
8. Cigarette smoking and nicotine addiction
9. Brief interventions for alcohol problems: A review
10. Social support and outcome of alcoholism treatment: An exploratory analysis
11. Alcohol detoxification and withdrawal seizures: Clinical support for a kindling hypothesis
12. Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: Preliminary findings
13. Suppression of psychoactive effects of cocaine by active immunization
14. Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy
15. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers
16. Methadone maintenance and addicts' risk of fatal heroin overdose
17. Alcohol and injuries: A review of international emergency room studies
18. Clinical course of gamma-hydroxybutyrate overdose
19. Epidemiology of alcohol-related violence
20. Naltrexone pharmacotherapy for opioid dependent federal probationers
21. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers
22. Severe gamma-hydroxybutyrate withdrawal: A case report and literature review
23. Medical complications of cocaine abuse
24. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: Short and long-term results
25. Helping your patients to quit smoking
26. A novel strategy for the treatment of cocaine addiction
27. Long-term outcome of patients treated with methadone maintenance
28. Methadone treatment of randomly selected criminal addicts
29. Testing the generalizability of intervening mechanism theories: Understanding the effects of adolescent drug use prevention interventions
30. Reducing suicide potential among highrisk youth: Tests of a school-based prevention program
31. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms
32. Nicotine replacement therapy
33. Opiate withdrawal
34. Opiate detoxification protocols: A clinical manual
35. Ethanol and cocaine interactions in humans: Cardiovascular consequences
36. Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital
37. High blood alcohol levels in women: The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism
38. Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependence
39. Cocaine addiction: Psychology and neurophysiology
40. Desipramine facilitation of initial cocaine abstinence
41. Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction: A meta-analysis of the randomized, controlled trials
42. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: Two placebo-controlled, double-blind trials
43. Replacement medication for cocaine dependence: Methylphenidate
44. The Swedish methadone maintenance program: A controlled study
45. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse
46. Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients
47. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism
48. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence
49. A comparison of sustained-release bupropion and placebo for smoking cessation
50. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
51. Evaluation of clinic attendance schedules for LAAM and methadone: A controlled study
52. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey
53. Anxiety disorders
54. Ultrarapid opiate detoxification
55. An open trial of sertraline for cocaine abuse
56. Carbamazepine treatment of cocaine dependence: A placebo-controlled trial
57. Cocaine-associated rhabdomyolysis causing renal failure in pregnancy
58. A tale of novel intoxication: Seven cases of gamma-hydroxybutyric acid overdose
59. A tale of novel intoxication: A review of the effects of gamma-hydroxybutyric acid with recommendations for management
60. A cooperative clinical study of methadyl acetate: I. Three-times-a-week regimen
61. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal
62. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence
63. A clinical, controlled study of 1-alpha-acetylmethadol in the treatment of narcotic addiction
64. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes
65. Pharmacological management of alcohol withdrawal: A meta-analysis and evidence-based practice guideline
66. Concurrent cocaine-ethanol ingestion in humans: Pharmacology, physiology, behavior, and the role of cocaethylene
67. Lasting neuropsychiatric sequelae of (+-)methylenedioxy-methamphetamine ('ecstasy') in recreational users
68. MDMA ("ecstasy") and panic disorder: Induction by a single dose
69. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
70. Chronic paranoid psychosis after misuse of MDMA ("ecstasy")
71. Ten years of 'ecstasy'
72. Hepatic rupture in pregnancy associated with cocaine use
73. Memory deficits associated with recreational use of "ecstasy" (MDMA)
74. Alcohol and crimes of violence: Present issues
75. Generalized seizures and cocaine abuse
76. Effective medical treatment of opiate addiction
77. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong
78. Alcohol: The drug
79. Myths about the treatment of addiction
80. Naltrexone in the treatment of alcoholism: A clinical review
81. Rapid and ultrarapid opioid detoxification techniques
82. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic
83. Cocaine-induced angina pectoris and acute myocardial infarction in patients younger than 40 years
84. Fluoxetine treatment of cocaine abuse in heroin addicts
85. Levo-alpha-acetylmethadol (LAAM): Clinical, research, and policy issues of a new pharmacotherapy for opioid addiction
86. A 3-year progress report on the implementation of LAAM in the United States
87. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study
88. Ecstasy (3,4-methylenedioxymethamphetamine): History, neurochemistry, and toxicology
89. Recreational drugs: Current trends in the 90s
90. Nicotine addiction and treatment
91. Physician unawareness of serious substance abuse
92. The impact of a brief motivational intervention with opiate users attending a methadone program
93. Alternative strategies of opiate detoxification: Evaluation of the so-called ultra-rapid detoxification
94. Subarachnoid hemorrhage precipitated by cocaine smoking
95. Alcohol, barbiturate and benzodiazepine withdrawal syndromes: Clinical management
96. Methadyl acetate and methadone: An open comparison
97. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation
98. Dose-response effects of methadone in the treatment of opioid dependence
99. Opioid analgesics and antagonists
100. Responsible prescribing of controlled substances
101. Fatal multi-organ failure after suicidal overdose with MDMA, 'ecstasy': Case report and review of the literature
102. Role of maintenance treatment in opioid dependence
103. Tricyclic antidepressants in the treatment of alcoholism and drug abuse
104. Acamprosate: A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification
105. Abuse of prescription drugs
106. The drug treatment of alcohol withdrawal symptoms: A systematic review
107. Multiple cocaine-induced seizures and corresponding cocaine and metabolite concentrations
108. Smoking cessation: Part 2 - Pharmacologic approaches
109. Substance abuse and emergency psychiatry